Keywords: schering, ag, starts, trial, compare, betaferon, copaxone

Schering AG starts trial to compare Betaferon and Copaxone

Article | 08 July 2002

Print This

Schering AG of Germany has announced the initiation of the BEYOND(Betaseron Efficacy Yielding Outcomes of a New Dose) study, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in